GENE ONLINE|News &
Opinion
Blog

2022-01-07| APAC

GeneOnline’s Top 10 Hong Kong Biotech IPOs of 2021

by GeneOnline
Share To
Hong Kong is Asia’s largest and the world’s second-largest destination for biotech companies wanting to go public. Amidst the backdrop of COVID-19 and changes in the political and regulatory environment in 2021, companies have forged on to make a splash on the HKEX. Here are 10 of them, ranked by the size of their IPOs. 

GO Prime with only $1.49 now

SUBSCRIBE NOW
LATEST
Alliance for Clinical Trials in Oncology Highlights Research Initiatives on World Breast Cancer Research Day
2026-08-18
Great Science Is Only the First Step Toward U.S. Healthcare Success
2026-08-18
European Patent Office Grants Godavari Biorefineries Patent for Anti-Cancer Drug Formulation
2026-08-18
One in 20 Australian Women Now Receive Intravenous Iron Infusions
2026-08-18
UL Research Institutes Appoints Dr. Chao-Yang Wang to Lead Electrochemical Safety Research Institute
2026-08-17
SUNY Polytechnic Institute Receives $15,000 Grant to Develop Mechanical Lung Model
2026-08-17
MetaboAnalyst 6.0 Released for LC-MS2 Environmental Exposure and Dose-Response Analysis
2026-08-17
READ MORE
EVENT
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
2026-10-23
ESMO Congress 2026 (Oncology Breakthroughs)
Madrid, Spain
SEE MORE
Scroll to Top